370 related articles for article (PubMed ID: 31496656)
1. eIF2α promotes vascular remodeling via autophagy in monocrotaline-induced pulmonary arterial hypertension rats.
Guo L; Li Y; Tian Y; Gong S; Chen X; Peng T; Wang A; Jiang Z
Drug Des Devel Ther; 2019; 13():2799-2809. PubMed ID: 31496656
[TBL] [Abstract][Full Text] [Related]
2. Corosolic acid attenuates platelet-derived growth factor signaling in macrophages and smooth muscle cells of pulmonary arterial hypertension.
Yamamura A; Fujiwara M; Kawade A; Amano T; Hossain A; Nayeem MJ; Kondo R; Suzuki Y; Inoue Y; Hayashi H; Suzuki S; Sato M; Yamamura H
Eur J Pharmacol; 2024 Jun; 973():176564. PubMed ID: 38614383
[TBL] [Abstract][Full Text] [Related]
3. Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension.
Chen X; Yu X; Lian G; Tang H; Yan Y; Gao G; Huang B; Luo L; Xie L
Biomed Pharmacother; 2024 May; 174():116505. PubMed ID: 38574614
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-663 prevents monocrotaline-induced pulmonary arterial hypertension by targeting TGF-β1/smad2/3 signaling.
Li P; Song J; Du H; Lu Y; Dong S; Zhou S; Guo Z; Wu H; Zhao X; Qin Y; Zhu N
J Mol Cell Cardiol; 2021 Dec; 161():9-22. PubMed ID: 34339758
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal.
Yang Y; Yin L; Zhu M; Song S; Sun C; Han X; Xu Y; Zhao Y; Qi Y; Xu L; Peng JY
Biomed Pharmacother; 2021 Jan; 133():111056. PubMed ID: 33378960
[TBL] [Abstract][Full Text] [Related]
6. Regulatory effects of Prohibitin 1 on proliferation and apoptosis of pulmonary arterial smooth muscle cells in monocrotaline-induced PAH rats.
Cao YY; Ba HX; Li Y; Tang SY; Luo ZQ; Li XH
Life Sci; 2020 Jun; 250():117548. PubMed ID: 32173312
[TBL] [Abstract][Full Text] [Related]
7. Activation of the p62-Keap1-Nrf2 pathway improves pulmonary arterial hypertension in MCT-induced rats by inhibiting autophagy.
Jiang G; Shi LF; Li LJ; Duan XJ; Zheng ZF
FASEB J; 2024 Feb; 38(3):e23452. PubMed ID: 38308640
[TBL] [Abstract][Full Text] [Related]
8. CircItgb5 promotes synthetic phenotype of pulmonary artery smooth muscle cells via interacting with miR-96-5p and Uba1 in monocrotaline-induced pulmonary arterial hypertension.
Su H; Zhu H; Wang S; Li Y; Yan C; Wang J; Ying K
Respir Res; 2023 Jun; 24(1):165. PubMed ID: 37344798
[TBL] [Abstract][Full Text] [Related]
9. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
[TBL] [Abstract][Full Text] [Related]
10. Nestin represents a potential marker of pulmonary vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease.
Zhou JJ; Li H; Qian YL; Quan RL; Chen XX; Li L; Li Y; Wang PH; Meng XM; Jing XL; He JG
J Mol Cell Cardiol; 2020 Dec; 149():41-53. PubMed ID: 32950539
[TBL] [Abstract][Full Text] [Related]
11. PDGF/MEK/ERK axis represses Ca
Deng L; Chen J; Wang T; Chen B; Yang L; Liao J; Chen Y; Wang J; Tang H; Yi J; Kang K; Li L; Gou D
Am J Physiol Cell Physiol; 2021 Jan; 320(1):C66-C79. PubMed ID: 32966125
[TBL] [Abstract][Full Text] [Related]
12. The novel roles of YULINK in the migration, proliferation and glycolysis of pulmonary arterial smooth muscle cells: implications for pulmonary arterial hypertension.
Wu YC; Wang WT; Yang MC; Su YT; Yeh JL; Hsu JH; Wu JR
Biol Res; 2023 Dec; 56(1):66. PubMed ID: 38057829
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel alleviates monocrotaline-induced pulmonary arterial hypertension via inhibition of FoxO1-mediated autophagy.
Feng W; Wang J; Yan X; Zhai C; Shi W; Wang Q; Zhang Q; Li M
Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):605-613. PubMed ID: 30683943
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin S promotes the development of pulmonary arterial hypertension.
Chang CJ; Hsu HC; Ho WJ; Chang GJ; Pang JS; Chen WJ; Huang CC; Lai YJ
Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L1-L13. PubMed ID: 31017016
[TBL] [Abstract][Full Text] [Related]
15. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
16. Isoquercitrin protects against pulmonary hypertension via inhibiting PASMCs proliferation.
Zhang Y; Cui Y; Deng W; Wang H; Qin W; Huang C; Li C; Zhang J; Guo Y; Wu D; Guo H
Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):362-370. PubMed ID: 27873355
[TBL] [Abstract][Full Text] [Related]
17. CYLD mediates human pulmonary artery smooth muscle cell dysfunction in congenital heart disease-associated pulmonary arterial hypertension.
Zhou JJ; Li H; Li L; Li Y; Wang PH; Meng XM; He JG
J Cell Physiol; 2021 Sep; 236(9):6297-6311. PubMed ID: 33507567
[TBL] [Abstract][Full Text] [Related]
18. Krüppel-like Factor 7 inhibits proliferation and migration of pulmonary smooth muscle cells via p21 activation.
Zeng Z; Zhou X; Zhu Y; Huang X; Tong X; Liu J; Zhang T; Wu W
Eur J Pharmacol; 2023 Feb; 940():175473. PubMed ID: 36566916
[TBL] [Abstract][Full Text] [Related]
19. CGRP attenuates pulmonary vascular remodeling by inhibiting the cGAS-STING-NFκB pathway in pulmonary arterial hypertension.
Yan X; Huang J; Zeng Y; Zhong X; Fu Y; Xiao H; Wang X; Lian H; Luo H; Li D; Guo R
Biochem Pharmacol; 2024 Apr; 222():116093. PubMed ID: 38408681
[TBL] [Abstract][Full Text] [Related]
20. LncRNA H19 promotes the proliferation of pulmonary artery smooth muscle cells through AT
Su H; Xu X; Yan C; Shi Y; Hu Y; Dong L; Ying S; Ying K; Zhang R
Respir Res; 2018 Dec; 19(1):254. PubMed ID: 30547791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
